National Health Investors Inc
NHI NYSE· Real Estate Investment Trusts
Last close · Oct 26, 2026
$67.46
KIRA · Stoqly’s AI analyst, in plain words
- National Health Investors Inc had $376M of revenue in fiscal 2025, up 12.1% on the year before. Over five years, revenue changed +2.5% a year on average.
- National Health Investors Inc made $142M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −2.7% a year.
- Free cash flow was −$57.5M in fiscal 2025, −15.3% of revenue.
- National Health Investors Inc returned $170M to shareholders in fiscal 2025. The diluted share count rose 6.7%.
Market cap
$3.3B
P/E
19.5x
Revenue
$376M
Net income
$142M
Free cash flow
−$57.5M
Operating margin
—
National Health Investors Inc in 30 seconds · fiscal 2025
Are sales growing?
+12.1%
Yes. Sales grew 12.1% last year.
Does it make a profit?
37.9%
Yes. It keeps 37.9% of every sale as profit.
Does profit turn into cash?
−15.3%
No. It spent more cash than it brought in.
How is the share priced?
19.5x
One share costs 19.5 times its yearly profit per share.
What National Health Investors Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- NATIONAL HEALTH INVESTORS INC
- CIK
- 0000877860
National Health Investors Inc · NHI
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $299M | $278M | $320M | $335M | $376M |
| Revenue growth | −10.2% | −6.9% | 15.0% | 4.8% | 12.1% |
| Net interest income | — | $240M | $269M | — | — |
| Net income | $112M | $66.4M | $136M | $138M | $142M |
| Net margin | 37.4% | 23.9% | 42.4% | 41.2% | 37.9% |
| Diluted EPS | $2.44 | $1.48 | $3.13 | $3.13 | $3.02 |
| Cash | |||||
| Cash from operations | $211M | $185M | $184M | $208M | $237M |
| Capital expenditure | $50.3M | $11.0M | $49.6M | $158M | $294M |
| Free cash flow | $161M | $174M | $135M | $49.8M | −$57.5M |
| FCF margin | 53.7% | 62.7% | 42.2% | 14.9% | −15.3% |
| Dividends paid | $183M | $162M | $156M | $157M | $170M |
| Share buybacks | $0.0M | $152M | $0.0M | $0.0M | — |
| Share count change | 2.3% | −2.0% | −3.1% | 1.6% | 6.7% |
| Debt and strength | |||||
| Cash and short-term investments | $37.4M | $19.3M | $22.3M | $24.3M | $19.6M |
| Loans, net | $300M | $233M | $245M | $269M | $203M |
| Shareholders' equity | $1.5B | $1.3B | $1.3B | $1.4B | $1.5B |
| Returns and quality | |||||
| Return on equity | 7.4% | 4.8% | 10.7% | 10.5% | 9.8% |
| Return on tangible equity | 7.4% | 5.2% | 10.8% | 10.1% | 9.3% |
Insiders bought, 12 months
$0.2M
2 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
National Health Investors Inc · NHI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $67.46 a share, the company is worth $3.3B: 19.5 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0000877860). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.